Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience

by Nethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, Guy Ben-Betzalel, Jacob Schachter, Tomer Meirson, Gal Markel
Published 2021-06-01

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma

by Nethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, Ronnie Shapira-Frommer, Yael Steinberg-Silman, Neta Gochman, Jacob Schachter, Tomer Meirson, Gal Markel
Published 2020-08-01

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

by Ronnie Shapira-Frommer, Elad Jacoby, Orit Itzhaki, Abraham Nissani, Gal Markel, Jacob Schachter, Shaked Lev-Ari, Tomer Meirson, Nethanel Asher, Guy Ben-Betzalel, Michal J. Besser
Published 2021-05-01

Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.

by Orit Itzhaki, Eyal Greenberg, Bruria Shalmon, Adva Kubi, Avraham J Treves, Ronnie Shapira-Frommer, Camilla Avivi, Rona Ortenberg, Eytan Ben-Ami, Jacob Schachter, Michal J Besser, Gal Markel
Published 2013-01-01

318 Olaparib plus pembrolizumab in patients with previously treated advanced solid tumors with homologous recombination repair mutation and/or homologous recombination repair defic...

by Andrew E Hendifar, Douglas A Levine, Ronnie Shapira-Frommer, Sanatan Saraf, Michele Maio, Timothy A Yap, Mallika Dhawan, Taofeek K Owonikoko, Miguel Quintela-Fandino, Ping Qiu, Fan Jin, Alexander Gozman
Published 2020-11-01